Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab

Published:2018 Issue:1 Volume:98 Page:151-152
ISSN:0001-5555
Container-title:Acta Dermato Venereologica
language:en
Short-container-title:Acta Derm Venerol

Author:

Schuch A,Fischer T,Boehner A,Biedermann T,Volz T

Publisher

Medical Journals Sweden AB

Subject

Dermatology,General Medicine

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa;Expert Opinion on Biological Therapy;2024-04-02

2. S2k-Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa (ICD-10-Code: L73.2);Aktuelle Dermatologie;2024-02

3. Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study;Clinical, Cosmetic and Investigational Dermatology;2024-01

4. Treating refractory acne conglobata with secukinumab: A case report;The Journal of Dermatology;2023-09-19

5. Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies;Dermatology and Therapy;2023-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP